Trials / Not Yet Recruiting
Not Yet RecruitingNCT07535242
Serum GFAP, NfL, VEGF and Clinical Progression in Progressive MS
Investigation of the Relationship Between Serum GFAP, NfL, and VEGF Levels and Clinical Progression Markers in Progressive Multiple Sclerosis
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 22 (estimated)
- Sponsor
- Ondokuz Mayıs University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to investigate whether the biomarkers GFAP, NfL, and VEGF-recently considered important guides for better understanding the pathophysiology of MS-also serve as indicators of clinical progression in MS.
Conditions
Timeline
- Start date
- 2026-04-21
- Primary completion
- 2026-04-30
- Completion
- 2026-05-05
- First posted
- 2026-04-17
- Last updated
- 2026-04-17
Source: ClinicalTrials.gov record NCT07535242. Inclusion in this directory is not an endorsement.